The ability of AGX51 to phenocopy the consequences of Id genetic loss suggests that in addition to being a useful biologic tool, AGX51 can serve as a lead compound that can be developed to provide clinical benefit for a variety of Id-related cancers. Here, ID1 is linked to cancer.